Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent

This publication has 49 references indexed in Scilit:

• Selection of thrombolytic therapy for individual patients: Development of a clinical model
  American Heart Journal, 1997
• Staphylokinase Requires NH2-terminal Proteolysis for Plasminogen Activation
  Published by Elsevier ,1997
• Interactions between Staphylokinase, Plasmin(ogen), and Fibrin
  Published by Elsevier ,1996
• Comparative Antigenicity of Recombinant Wild-Type Staphylokinase (SakSTAR) and a Selected Mutant (SakSTAR.M38) in a Baboon Thrombolysis Model
  Journal of Cardiovascular Pharmacology, 1996
• High Yield Production and Purification of Recombinant Staphylokinase for Thrombolytic Therapy
  Nature Biotechnology, 1994
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase
  European Journal of Biochemistry, 1993
• On the molecular interactions between plasminogen-staphylokinase, α2-antiplasmin-formula> and fibrin
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1992
• Staphlococcal Coagulation and Fibrinolysis
  Nature, 1948
• STREPTOCOCCAL FIBRINOLYSIS: A PROTEOLYTIC REACTION DUE TO A SERUM ENZYME ACTIVATED BY STREPTOCOCCAL FIBRINOLYSIN
  The Journal of general physiology, 1945